Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MDI-1228 by Henan Maiyingnuo Pharmaceutical Technology for Allergic Conjunctivitis: Likelihood of Approval
MDI-1228 is under clinical development by Henan Maiyingnuo Pharmaceutical Technology and currently in Phase I for Allergic Conjunctivitis. According to...